- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: solid malignancies
Total 10951 results
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, Denmark, Spain, Belgium, United Kingdom, Russian Federation, Netherlands
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
AstraZenecaCompleted
-
InnoPharmax Inc.CompletedAdvanced Solid Malignancies | Malignant LymphomasTaiwan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
Novartis PharmaceuticalsTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Jiangsu HengRui Medicine Co., Ltd.307 Hospital of PLA; Peking University Cancer Hospital & InstituteCompletedAdvanced Solid MalignanciesChina
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States
-
AHS Cancer Control AlbertaCross Cancer InstituteTerminatedNon-small Cell Lung Cancer | Advanced Solid MalignanciesCanada
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
Taipei Medical UniversityCompletedAdvanced Solid MalignanciesTaiwan
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.CompletedHematologic Malignancies | Malignant Solid TumorUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced CancerUnited States, Korea, Republic of, Canada
-
University of Colorado, DenverSpringWorks Therapeutics, Inc.No longer availableNeoplasm | Desmoid TumorUnited States
-
PlexxikonTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Solid TumorsUnited States
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Genentech, Inc.CompletedHematologic Malignancies | TumorsSpain, France, United States, United Kingdom
-
National Cancer Institute (NCI)CompletedRenal Cell Carcinoma | Breast Cancer | Lung Cancer | Non-Hodgkin Lymphoma | Colon CancerUnited States
-
Hutchison Medipharma LimitedTerminated
-
M.D. Anderson Cancer CenterVioQuest PharmaceuticalsCompletedAdvanced Cancer | Solid TumorsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Washington University School of MedicineCompletedSolid Tumor | Solid MalignancyUnited States
-
National Cancer Institute (NCI)Completed
-
EMD SeronoCompletedSolid TumorUnited States
-
ImaginAb, Inc.CompletedHodgkin Lymphoma | Positron-Emission Tomography | Immunomodulation | Metastatic Solid MalignanciesUnited States
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Kiromic, Inc.WithdrawnCancer | Metastatic Solid Malignancies
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
Immune System Key LtdCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustAstraZenecaCompleted
-
CelgeneWithdrawnSolid TumorUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedMalignant Solid Tumour | Hematologic Malignancies | Planned Hematopoietic Cell TransplantationUnited States
-
NHS Greater Glasgow and ClydeMerck Sharp & Dohme LLC; Cancer Research UK; University of Southampton; Queen's... and other collaboratorsUnknownPancreatic Neoplasms | Mesothelioma | Carcinoma, Non-small-cell LungUnited Kingdom
-
Emory UniversityNovartis PharmaceuticalsCompletedLung Cancer | Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedSolid TumorsAustria, Belgium, United States, Italy, Denmark, Spain, Japan
-
Celldex TherapeuticsCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma | Marginal Zone B Cell Lymphoma) | Any T-cell Malignancy | Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma | Hormone-refractory Prostate Adenocarcinoma, Ovarian... and other conditionsUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
Incyte CorporationTerminatedBreast Cancer | Pancreatic Cancer | Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Advanced Cancer | NHL (Non-Hodgkin Lymphoma) | UC (Ureter and Urethera)United States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Washington University School of MedicineCompletedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Hoffmann-La RocheCompleted
-
Incyte CorporationNovartis PharmaceuticalsCompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States